BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31838158)

  • 1. Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
    Percik R; Shlomai G; Tirosh A; Tirosh A; Leibowitz-Amit R; Eshet Y; Greenberg G; Merlinsky A; Barhod E; Steinberg-Silman Y; Sella T
    Autoimmun Rev; 2020 Feb; 19(2):102454. PubMed ID: 31838158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review.
    Wang F; Shi X; Yu X; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1326684. PubMed ID: 38318292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated autoimmune adrenocorticotropic hormone deficiency: A positive predictor of survival among cancer patients treated with checkpoint inhibitors.
    Aviv-Shimoni S; Uri I; Milloh-Raz H; Percik R
    Autoimmun Rev; 2023 Sep; 22(9):103387. PubMed ID: 37352903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S; Leiter A; Galsky M; Gallagher EJ
    J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
    Zöllner EW; Lombard CJ; Galal U; Hough FS; Irusen EM; Weinberg E
    Pediatrics; 2012 Dec; 130(6):e1512-9. PubMed ID: 23147980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamus-pituitary-adrenal axis in HIV disease.
    Freda PU; Bilezikian JP
    AIDS Read; 1999; 9(1):43-50. PubMed ID: 12728883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Scott ES; Long GV; Guminski A; Clifton-Bligh RJ; Menzies AM; Tsang VH
    Eur J Endocrinol; 2018 Feb; 178(2):173-180. PubMed ID: 29187509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
    Johnson J; Goldner W; Abdallah D; Qiu F; Ganti AK; Kotwal A
    J Natl Compr Canc Netw; 2023 Feb; 21(3):281-287. PubMed ID: 36828029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis.
    Fischli S; Jenni S; Allemann S; Zwahlen M; Diem P; Christ ER; Stettler C
    J Clin Endocrinol Metab; 2008 Feb; 93(2):539-42. PubMed ID: 17986637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges.
    Martin-Grace J; Dineen R; Sherlock M; Thompson CJ
    Clin Chim Acta; 2020 Jun; 505():78-91. PubMed ID: 32035851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
    Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
    Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis.
    Habib G; Jabbour A; Salman J; Hakim G; Haddad H
    J Clin Anesth; 2013 Dec; 25(8):629-33. PubMed ID: 23988802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanoma.
    Kassi E; Angelousi A; Asonitis N; Diamantopoulos P; Anastasopoulou A; Papaxoinis G; Kokkinos M; Giovanopoulos I; Kyriakakis G; Petychaki F; Savelli A; Benopoulou O; Gogas H
    Cancer Med; 2019 Nov; 8(15):6585-6594. PubMed ID: 31518074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor-induced secondary adrenal insufficiency.
    Yano S; Ashida K; Sakamoto R; Sakaguchi C; Ogata M; Maruyama K; Sakamoto S; Ikeda M; Ohe K; Akasu S; Iwata S; Wada N; Matsuda Y; Nakanishi Y; Nomura M; Ogawa Y
    Eur J Cancer; 2020 May; 130():198-203. PubMed ID: 32229416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of hypothalamic-pituitary-adrenal axis suppression secondary to intrabursal injection of different glucocorticoids: a pilot study.
    Guaraldi F; Gori D; Calderoni P; Castiello E; Pratelli L; Leporati M; Arvat E; Battaglia M
    J Endocrinol Invest; 2019 Sep; 42(9):1117-1124. PubMed ID: 30877658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery rate of adrenal function after surgery in patients with acromegaly is higher than in those with non-functioning pituitary tumors: a large single center study.
    Yedinak C; Hameed N; Gassner M; Brzana J; McCartney S; Fleseriu M
    Pituitary; 2015 Oct; 18(5):701-9. PubMed ID: 25673267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.